Aksh Optifibre Q3 FY24 results : loss at ₹4.21Cr, Revenue decreased by 24.15% YoY
Aksh Optifibre declared their Q3 FY24 results on 14 Feb, 2024. The topline decreased by 24.15% & the loss came at ₹4.21cr.
It is noteworthy that Aksh Optifibre had declared profit of ₹1.19cr in the previous fiscal year same period.
As compared to the previous quarter, the revenue declined by 14.28%.
The Selling, general & administrative expenses declined by 4.4% q-o-q & decreased by 4.79% Y-o-Y.
The operating income was down by 144.02% q-o-q & decreased by 122.36% Y-o-Y.
The EPS is ₹-0.31 for Q3 FY24, which decreased by 429.05% Y-o-Y.
Aksh Optifibre has delivered -10.19% return in the last 1 week, 8.68% return in the last 6 months, and -1.65% YTD return.
Currently, Aksh Optifibre has a market cap of ₹193.61 Cr and a 52wk high/low of ₹15.85 & ₹8 respectively.
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 51.72 | 60.34 | -14.28% | 68.19 | -24.15% |
| Selling/ General/ Admin Expenses Total | 5.49 | 5.74 | -4.4% | 5.77 | -4.79% |
| Depreciation/ Amortization | 5.45 | 5.5 | -0.94% | 6.3 | -13.55% |
| Total Operating Expense | 52.94 | 57.57 | -8.05% | 62.75 | -15.63% |
| Operating Income | -1.22 | 2.76 | -144.02% | 5.44 | -122.36% |
| Net Income Before Taxes | -4.13 | -0.67 | -518.33% | 3.27 | -226.48% |
| Net Income | -4.21 | -4.93 | +14.7% | 1.19 | -454.58% |
| Diluted Normalized EPS | -0.31 | -0.4 | +22.01% | 0.09 | -429.05% |
FAQs
Question : What is the Q3 FY24 profit/Loss as per company?
Ans : ₹-4.21Cr
Question : What is Q3 FY24 revenue?
Ans : ₹51.72Cr
Stay updated on quarterly results with our results calendar
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it’s all here, just a click away! Login Now!
Download Finplay News App to get Daily Market Updates & Live Business News.
More
Less
Published: 17 Feb 2024, 03:03 AM IST
Ganesh
http://ganesh@finplay.inFinance enthusiast, Mutual fund expert.